BioWorld - Saturday, January 17, 2026

BioWorld Science

Oct. 4, 2019

View Archived Issues

Targeting ATP6V1A subunit in the v-ATPase complex inhibits mTORC1 signaling and activates autophagy

Read More

Allogene Therapeutics initiates phase I study of ALLO-715

Read More

FDA approves Entresto for pediatric heart failure

Read More

AL-008 potentiates the antitumor effector functions of macrophages and dendritic cells

Read More

TERT gene fusions as novel biomarkers in metastatic Leydig cell tumors

Read More

Phase I safety and PK data presented for novel CXCR4 antagonist YF-H-2015005

Read More

Black Diamond Therapeutics describes preclinical activity of mutant EGFR/HER2 inhibitor BDTX-189

Read More

Universita degli Studi di Siena discovers new antivirals

Read More

New arginase inhibitors identified at Merck & Co.

Read More

Ethris and Munster University Hospital receive support for work in primary ciliary dyskinesia

Read More

Voronoi patents EGFR/JAK3 inhibitors

Read More

Free fatty acid receptor 4 agonists disclosed by Axxam

Read More

PARAGON-HF results for sacubitril/valsartan in heart failure with preserved ejection fraction

Read More

Liver-targeted uncouplers reverse type 2 diabetes, fatty liver in primates

Read More

FDA approves Descovy for HIV-1 PrEP

Read More

Arbutus discontinues development of AB-506 following cases of acute hepatitis

Read More

Healx collaborates with ICR to discover treatments for diffuse intrinsic pontine glioma

Read More

Prometheus Biosciences and Takeda collaborate to develop novel IBD therapies

Read More

Deinove studies DNV-3837 in phase II for C. difficile infection

Read More